Find policies, billing codes, payers, states, and providers

HCPCS G0483: Definitive Drug Test, 22+ Drug Classes

HCPCS Level II code G0483 represents a definitive laboratory drug test using advanced analytical methods (e.g., GC/MS, LC/MS) with stable isotope/internal standards and matrix-matched calibration, performed for 22 or more drug classes per day. This code captures high-complexity toxicology testing that distinguishes structural isomers and includes specimen validity assessment. Nationally, G0483 matters because it defines billing and clinical expectations for comprehensive confirmatory drug panels used in clinical care, forensic contexts, and substance use monitoring programs.

Key payers in typical coverage analyses include Aetna, Blue Cross Blue Shield plans, Cigna Health, UnitedHealthcare, and Medicare. Readers will find benchmarks and comparative guidance on how this code is described and applied across payer policies, an overview of clinical contexts where such definitive testing is used, and notes on coding nuances relevant to comprehensive, high-complexity toxicology panels. The publication summarizes reimbursement considerations, common modifiers submitted with complex laboratory services, and implications for lab operations and documentation when providing multi-class definitive testing.

Customize your policy alerts

Sign up for hcpcs G0483 policy alerts

Get alerted when payer policies referencing G0483 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

HCPCS Level II code G0483 describes a definitive drug testing service that uses advanced analytical methods capable of identifying individual drugs and distinguishing structural isomers. The test includes use of technologies such as GC/MS or LC/MS (single or tandem), requires stable isotope or other universally recognized internal standards in all samples, and mandates method- or drug-specific calibration with matrix-matched quality control material. The service may be reported as qualitative or quantitative and includes specimen validity testing. The descriptor specifies testing for 22 or more drug classes, including metabolites if performed, and is reported on a per day basis.

Service type: Definitive toxicology/drug identification testing (qualitative or quantitative)

Typical site of service: Clinical laboratory or hospital laboratory setting

Explore openpayer tools

View all tools

Find policies, billing codes, payers, states, and providers

HCPCS G0483: Definitive Drug Test, 22+ Drug Classes

Customize your policy alerts

Sign up for hcpcs G0483 policy alerts

Get alerted when payer policies referencing G0483 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

Service type: Definitive toxicology/drug identification testing (qualitative or quantitative)

Typical site of service: Clinical laboratory or hospital laboratory setting

Clinical & Coding Specifications

Clinical Context

A 38-year-old patient enrolled in an employer-sponsored substance use monitoring program presents to an outpatient laboratory for confirmatory toxicology testing after an initial positive point-of-care immunoassay. The specimen (urine) is collected under observed conditions, labeled, and transported to a certified laboratory. The laboratory performs a definitive, qualitative and/or quantitative testing panel using gas chromatography–mass spectrometry (gc/ms) or liquid chromatography–mass spectrometry (lc/ms) methods with stable isotope internal standards and matrix-matched calibration. Specimen validity testing (e.g., adulteration, dilution, substitution checks) is completed concurrently. Results are reported to the ordering clinician and the program case manager the same day or next business day, documenting identified parent drugs and metabolites across 22 or more drug classes, including any structural isomers distinguished by the method. Typical workflow steps: specimen collection and chain-of-custody documentation, accessioning, specimen validity testing, extraction and preparation, definitive lc/ms or gc/ms analysis with internal standards, method-specific calibration and quality control, data review by a laboratory director, and reporting of qualitative or quantitative results to the ordering provider and authorized payors or program administrators.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	When billing only the laboratory professional interpretation or review separate from technical processing (rare for most reference labs).
`59`	Distinct procedural service	When an unrelated service is performed the same day and should be reported separately from the drug testing service.
`62`	Two surgeons	If two qualified laboratory physicians share responsibility for complex testing oversight (uncommon).
`90`	Reference (outside) laboratory	When the specimen is sent to an outside reference laboratory for definitive `gc/ms` or `lc/ms` testing.
`TC`	Technical component	When billing only the instrument, supplies, and technical processing of the test without professional interpretation.
`26`	Professional component	When billing only the pathologist/clinical chemist professional component separate from the technical component.
`52`	Reduced services	When testing is partially reduced or limited relative to the full calibrated panel (e.g., limited analyte list for clinical reasons).
`53`	Discontinued procedure	If testing was started but discontinued due to specimen compromise or insufficient volume.
`90`	Reference laboratory (alternate)	Applied by some payors to indicate testing performed by an outside lab under contract.
`QK`	CLIA waived testing performed by a laboratory technician	Rarely applicable; use when personnel credentials match payer rules for waived testing segments.
`QX`	Modifier for CLIA-certified non-physician practitioners	When testing is performed under appropriate CLIA certification and billing rules for non-physician practitioners.
`QY`	Laboratory test ordered by another provider	When the ordering physician is different from the performing laboratory billing provider and payor requires this indicator.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist billing under their own NPI	When an advanced practice provider orders and bills for the service under applicable payor rules.
`90`	Outside laboratory payment indicator	When payor-specific adjudication requires marking tests performed by external labs.

Taxonomy Code	Specialty	Notes
174400000X	Clinical Pathology	Laboratory directors and clinical chemists overseeing definitive drug testing.
208000000X	Family Medicine	Ordering clinicians in outpatient monitoring, pain management, or occupational medicine.
261QM0800X	Toxicology	Specialists interpreting complex toxicology panels and counseling clinicians on results.
207R00000X	Anesthesiology	Ordering clinicians in perioperative or pain clinic settings who request definitive testing.
208D00000X	Internal Medicine	Primary care physicians managing substance use monitoring and chronic pain programs.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F11.20`	Opioid dependence, uncomplicated	Common indication for monitoring opioid metabolites and compliance with therapy.
`F10.20`	Alcohol dependence, uncomplicated	Used when comprehensive toxicology and specimen validity testing evaluate alcohol metabolites and misuse.
`Z79.891`	Long term (current) use of opiate analgesic	Chronic opioid therapy monitoring with definitive testing to ensure adherence and absence of illicit substances.
`T40.2X5A`	Poisoning by other opioids, accidental, initial encounter	For confirmatory testing in overdose evaluation and forensic interpretation.
`R78.89`	Finding of other substances and biologicals in urine	Generic code used when abnormal toxicology findings require definitive identification.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80305`	Drug test(s), presumptive, any number of drug classes; non-automated, with instrumented chemistry analyzers	Performed commonly as initial screening; positive screens may trigger definitive testing billed as `G0483`.
`80306`	Drug test(s), presumptive, any number of drug classes; automated, with instrumented chemistry analyzers	Automated immunoassay screening prior to definitive confirmatory testing by `G0483`.
`80307`	Drug test(s), presumptive, any number of drug classes; instant read, point of care	Point-of-care rapid screens that may prompt collection for definitive `gc/ms` or `lc/ms` confirmation billed as `G0483`.
`80320`	Drug confirmation, qualitative or quantitative, by gas chromatography/mass spectrometry (GC/MS), each drug class	Related confirmatory analytic methodology; specific CPT descriptions may overlap conceptually with `G0483` for definitive testing and are used in some payer policies.
`80502`	Amphetamine and/or methamphetamine, confirmatory, quantitative, each	Example of specific confirmatory CPTs for individual analytes that may be included within a broader `G0483` panel when itemized billing is required by a payor.

HCPCS G9490: Home Visit Assessment for Non-Homebound Patients

HCPCS-G0008-INFLUENZA-VACCINE-ADMINISTRATION

HCPCS G0008: Influenza Virus Vaccine Administration

HCPCS-G0009-PNEUMOCOCCAL-VACCINE-ADMINISTRATION

HCPCS G0009: Administration of Pneumococcal Vaccine

HCPCS-G0010-HEPATITIS-B-VACCINE-ADMINISTRATION

HCPCS G0010: Administration of Hepatitis B Vaccine

HCPCS-G0011-PREP-COUNSELING-HIV-RISK-REDUCTION-ADHERENCE

HCPCS G0011: Individual PrEP Counseling, HIV Risk Assessment

HCPCS-G0012-PRE-EXPOSURE-PROPHYLAXIS-INJECTION-HIV-PREVENTION

HCPCS G0012: Injection of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention

HCPCS-G0013-PREP-INDIVIDUAL-COUNSELING-HIV-RISK-REDUCTION

HCPCS G0013: Individual PrEP Counseling and HIV Risk Assessment

HCPCS-G0017-PSYCHOTHERAPY-CRISIS-FIRST-60-MINUTES-NON-OFFICE

HCPCS G0017: Psychotherapy for Crisis, First 60 Minutes

HCPCS-G0018-PSYCHOTHERAPY-CRISIS-ADDITIONAL-30-MINUTES-NON-OFFICE

HCPCS G0018: Psychotherapy for Crisis, Additional 30 Minutes

HCPCS-G0019-COMMUNITY-HEALTH-INTEGRATION-SDOH-CARE-COORDINATION

HCPCS G0019: Community Health Integration for Social Determinants of Health

Showing 1–10 of 1996

Frequently Asked Questions

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Explore openpayer tools

View all tools

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	When billing only the laboratory professional interpretation or review separate from technical processing (rare for most reference labs).
`59`	Distinct procedural service	When an unrelated service is performed the same day and should be reported separately from the drug testing service.
`62`	Two surgeons	If two qualified laboratory physicians share responsibility for complex testing oversight (uncommon).
`90`	Reference (outside) laboratory	When the specimen is sent to an outside reference laboratory for definitive `gc/ms` or `lc/ms` testing.
`TC`	Technical component	When billing only the instrument, supplies, and technical processing of the test without professional interpretation.
`26`	Professional component	When billing only the pathologist/clinical chemist professional component separate from the technical component.
`52`	Reduced services	When testing is partially reduced or limited relative to the full calibrated panel (e.g., limited analyte list for clinical reasons).
`53`	Discontinued procedure	If testing was started but discontinued due to specimen compromise or insufficient volume.
`90`	Reference laboratory (alternate)	Applied by some payors to indicate testing performed by an outside lab under contract.
`QK`	CLIA waived testing performed by a laboratory technician	Rarely applicable; use when personnel credentials match payer rules for waived testing segments.
`QX`	Modifier for CLIA-certified non-physician practitioners	When testing is performed under appropriate CLIA certification and billing rules for non-physician practitioners.
`QY`	Laboratory test ordered by another provider	When the ordering physician is different from the performing laboratory billing provider and payor requires this indicator.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist billing under their own NPI	When an advanced practice provider orders and bills for the service under applicable payor rules.
`90`	Outside laboratory payment indicator	When payor-specific adjudication requires marking tests performed by external labs.

Taxonomy Code	Specialty	Notes
174400000X	Clinical Pathology	Laboratory directors and clinical chemists overseeing definitive drug testing.
208000000X	Family Medicine	Ordering clinicians in outpatient monitoring, pain management, or occupational medicine.
261QM0800X	Toxicology	Specialists interpreting complex toxicology panels and counseling clinicians on results.
207R00000X	Anesthesiology	Ordering clinicians in perioperative or pain clinic settings who request definitive testing.
208D00000X	Internal Medicine	Primary care physicians managing substance use monitoring and chronic pain programs.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F11.20`	Opioid dependence, uncomplicated	Common indication for monitoring opioid metabolites and compliance with therapy.
`F10.20`	Alcohol dependence, uncomplicated	Used when comprehensive toxicology and specimen validity testing evaluate alcohol metabolites and misuse.
`Z79.891`	Long term (current) use of opiate analgesic	Chronic opioid therapy monitoring with definitive testing to ensure adherence and absence of illicit substances.
`T40.2X5A`	Poisoning by other opioids, accidental, initial encounter	For confirmatory testing in overdose evaluation and forensic interpretation.
`R78.89`	Finding of other substances and biologicals in urine	Generic code used when abnormal toxicology findings require definitive identification.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80305`	Drug test(s), presumptive, any number of drug classes; non-automated, with instrumented chemistry analyzers	Performed commonly as initial screening; positive screens may trigger definitive testing billed as `G0483`.
`80306`	Drug test(s), presumptive, any number of drug classes; automated, with instrumented chemistry analyzers	Automated immunoassay screening prior to definitive confirmatory testing by `G0483`.
`80307`	Drug test(s), presumptive, any number of drug classes; instant read, point of care	Point-of-care rapid screens that may prompt collection for definitive `gc/ms` or `lc/ms` confirmation billed as `G0483`.
`80320`	Drug confirmation, qualitative or quantitative, by gas chromatography/mass spectrometry (GC/MS), each drug class	Related confirmatory analytic methodology; specific CPT descriptions may overlap conceptually with `G0483` for definitive testing and are used in some payer policies.
`80502`	Amphetamine and/or methamphetamine, confirmatory, quantitative, each	Example of specific confirmatory CPTs for individual analytes that may be included within a broader `G0483` panel when itemized billing is required by a payor.

HCPCS G9490: Home Visit Assessment for Non-Homebound Patients

HCPCS-G0008-INFLUENZA-VACCINE-ADMINISTRATION

HCPCS G0008: Influenza Virus Vaccine Administration

HCPCS-G0009-PNEUMOCOCCAL-VACCINE-ADMINISTRATION

HCPCS G0009: Administration of Pneumococcal Vaccine

HCPCS-G0010-HEPATITIS-B-VACCINE-ADMINISTRATION

HCPCS G0010: Administration of Hepatitis B Vaccine

HCPCS-G0011-PREP-COUNSELING-HIV-RISK-REDUCTION-ADHERENCE

HCPCS G0011: Individual PrEP Counseling, HIV Risk Assessment

HCPCS-G0012-PRE-EXPOSURE-PROPHYLAXIS-INJECTION-HIV-PREVENTION

HCPCS G0012: Injection of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention

HCPCS-G0013-PREP-INDIVIDUAL-COUNSELING-HIV-RISK-REDUCTION

HCPCS G0013: Individual PrEP Counseling and HIV Risk Assessment

HCPCS-G0017-PSYCHOTHERAPY-CRISIS-FIRST-60-MINUTES-NON-OFFICE

HCPCS G0017: Psychotherapy for Crisis, First 60 Minutes

HCPCS-G0018-PSYCHOTHERAPY-CRISIS-ADDITIONAL-30-MINUTES-NON-OFFICE

HCPCS G0018: Psychotherapy for Crisis, Additional 30 Minutes

HCPCS-G0019-COMMUNITY-HEALTH-INTEGRATION-SDOH-CARE-COORDINATION

HCPCS G0019: Community Health Integration for Social Determinants of Health

Showing 1–10 of 1996

Frequently Asked Questions

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

OpenPayer

HCPCS G0483: Definitive Drug Test, 22+ Drug Classes

Sign up for hcpcs G0483 policy alerts

Billing Code Overview

OpenPayer

HCPCS G0483: Definitive Drug Test, 22+ Drug Classes

Sign up for hcpcs G0483 policy alerts

Billing Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References

HCPCS G0483: Definitive Drug Test, 22+ Drug Classes

Sign up for hcpcs G0483 policy alerts

Billing Code Overview

HCPCS G0483: Definitive Drug Test, 22+ Drug Classes

Sign up for hcpcs G0483 policy alerts

Billing Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

What does HCPCS code G0483 represent?

Which analytic methods and quality controls are required for a test billed under G0483?

Which modifiers are commonly used with G0483 and when are they applied?

How does G0483 relate to presumptive screening codes and other confirmatory CPTs?

In what clinical situations and specialties is G0483 typically used?

References

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

What does HCPCS code G0483 represent?

Which analytic methods and quality controls are required for a test billed under G0483?

Which modifiers are commonly used with G0483 and when are they applied?

How does G0483 relate to presumptive screening codes and other confirmatory CPTs?

In what clinical situations and specialties is G0483 typically used?

References